Skip to content

Fulgent Genetics, Inc. FLGT Finite Lived Intangible Assets - Gross

Finite Lived Intangible Assets - Gross at other companies

Myriad Genetics logo
Myriad GeneticsMYGN
$512M-14.1%
GeneDx Holdings logo
GeneDx HoldingsWGS
$221.5M+13.0%
Veracyte logo
VeracyteVCYT
$146.72M+5.2%
Azenta logo
AzentaAZTA
$363.08M
Labcorp Holdings logo
Labcorp HoldingsLH
Natera, Inc. logo
Natera, Inc.NTRA

Segments

By segment

See full
Laboratory Services$105.15M+26.5%
Therapeutic Development$2.3M

Other financials

Income statement

See full
Revenue$71.1M-3.2%
Gross profit$21.5M-24.2%
Operating income-$34.6M-74.9%
Net income-$24.8M-115%
EPS (diluted)-$0.80-116%

Balance sheet

See full
Cash & equivalents$23.4M-65.2%
Total debt$8.2M+40.5%
Total equity$1.0B-6.9%
Total assets$1.2B-4.1%

Cash flow

See full
Operating cash flow$7.1M+260%
CapEx$5.2M+10.3%
Free cash flow$1.9M+121%

Valuation

See full
Market cap$552.11M-7.1%
Enterprise value$536.92M+0.7%
P/S1.7×-0.3×

Profitability

See full
Gross margin38.7%-0.1pp
Operating margin-33.1%+17.4pp
Net margin-23%+43.3pp
FCF margin-36.9%

Returns & leverage

See full
Return on equity-6.8%+48.2pp
Debt / equity0.0×
Current ratio5.3×-1.0×

Questions, answered.

What does finite lived intangible assets - gross mean?
This metric tracks the total historical cost of intangible assets that have a defined useful life, such as patents, software licenses, or customer relationships. It excludes assets with indefinite lives like certain trademarks or goodwill. It is a key indicator of the company's investment in intellectual property and intangible competitive advantages.